Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1

The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic... Letters and conduct of the study; in the collection, management, analysis, and et al has a similar mean age and percentage of male patients, interpretation of the data; or in the preparation or approval of the manuscript; 1 3 higher percentage of atrial arrhythmias (22.7% vs 12.8% vs and decision to submit the manuscript for publication. 4 1 3 4 11.4% ) and device implantation (20.5% vs 13.5% vs 3.9% ); 1. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function consequently, we cannot explain the low occurrence of LVD. by non-invasive peripheral arterial tonometry predicts late cardiovascular In conclusion, we suggest the authors consider a cutoff of left adverse events. Eur Heart J. 2010;31(9):1142-1148. ventricular ejection fraction of 50% or less for defining LVD 2. Bonaca MP, Bhatt DL, Cohen M, et al; PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial and evaluate the clinical and electrocardiographic character- infarction. N Engl J Med. 2015;372(19):1791-1800. istics of the DM1 subgroup with LVD to explain what may be 3. Bonello L, Laine M, Kipson N, et al. Ticagrelor increases adenosine plasma the cause of this different occurrence of LVD in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1

The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1

Abstract

Letters and conduct of the study; in the collection, management, analysis, and et al has a similar mean age and percentage of male patients, interpretation of the data; or in the preparation or approval of the manuscript; 1 3 higher percentage of atrial arrhythmias (22.7% vs 12.8% vs and decision to submit the manuscript for publication. 4 1 3 4 11.4% ) and device implantation (20.5% vs 13.5% vs 3.9% ); 1. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function...
Loading next page...
 
/lp/american-medical-association/the-controversial-epidemiology-of-left-ventricular-dysfunction-in-DhXd5WYAJn
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2017.0927
Publisher site
See Article on Publisher Site

Abstract

Letters and conduct of the study; in the collection, management, analysis, and et al has a similar mean age and percentage of male patients, interpretation of the data; or in the preparation or approval of the manuscript; 1 3 higher percentage of atrial arrhythmias (22.7% vs 12.8% vs and decision to submit the manuscript for publication. 4 1 3 4 11.4% ) and device implantation (20.5% vs 13.5% vs 3.9% ); 1. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function consequently, we cannot explain the low occurrence of LVD. by non-invasive peripheral arterial tonometry predicts late cardiovascular In conclusion, we suggest the authors consider a cutoff of left adverse events. Eur Heart J. 2010;31(9):1142-1148. ventricular ejection fraction of 50% or less for defining LVD 2. Bonaca MP, Bhatt DL, Cohen M, et al; PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial and evaluate the clinical and electrocardiographic character- infarction. N Engl J Med. 2015;372(19):1791-1800. istics of the DM1 subgroup with LVD to explain what may be 3. Bonello L, Laine M, Kipson N, et al. Ticagrelor increases adenosine plasma the cause of this different occurrence of LVD in

Journal

JAMA CardiologyAmerican Medical Association

Published: Sep 10, 2017

References